Home > Insider Trading > Filing (0001012975-10-000039)

Filing Details

Accession Number:: 0001012975-10-000039
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-02-18 12:00:00
Reporting Period:: 2010-02-16

Filing Date:: 2010-02-18
Accepted Time:: 2010-02-18 19:01:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1131907	Micromet Inc.	MITI	Biological Products, (No Disgnostic Substances) (2836)	522243564

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1361712	Otello Stampacchia	C/O Omega Fund Management Uk Llp 32 Old Burlington Street London X0 W1S 3AT		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-02-16	8,000	$8.05	2,450,413	No	4	S	Indirect	By Fund
Common Stock	Disposition	2010-02-17	11,000	$8.00	2,439,413	No	4	S	Indirect	By Fund
Common Stock	Disposition	2010-02-18	25,000	$8.03	2,414,413	No	4	S	Indirect	By Fund

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Fund
No	4	S	Indirect	By Fund
No	4	S	Indirect	By Fund

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2009.
Consists of 5,327 shares sold by Omega Fund I, L.P. ("Omega I") and 2,673 shares sold by Omega Fund III, L.P. ("Omega III").
Consists of 7,324 shares sold by Omega I and 3,676 shares sold by Omega III.
Consists of 16,647 shares sold by Omega I and 8,353 shares sold by Omega III.
Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $8 to $8.10 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $8.00 to $8.00 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $8.00 to $8.08 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Consists of 1,631,631 shares beneficially owned by Omega I and 818,782 shares beneficially owned by Omega III.
Consists of 1,624,307 shares beneficially owned by Omega I and 815,106 shares beneficially owned by Omega III.
Consists of 1,607,660 shares beneficially owned by Omega I and 806,753 shares beneficially owned by Omega III.
Consists of securities held directly by Omega III. Omega Fund III GP, L.P. ("Omega III GPLP") is the general partner of Omega III. Omega Fund III G.P., Ltd. ("Omega III GPLtd") is the general partner of Omega III GPLP. Omega Fund Management Limited ("Omega Management") is the sole shareholder of Omega III GPLtd. Sigma Holding Limited ("Sigma") is the sole shareholder of Omega Management. Otello Stampacchia ("Stampacchia") is the sole shareholder of Sigma and is also a director of Micromet, Inc. Stampacchia disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Consists of securities held directly by Omega I. Omega Fund GP, Ltd. ("Omega GP") is the general partner of Omega I. Omega Management is the sole shareholder of Omega GP. Sigma is the sole shareholder of Omega Management. Stampacchia is the sole shareholder of Sigma and is also a director of Micromet, Inc. Stampacchia disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.